TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 4 | 1 | 4 | -1 | 7 | 20 | 35 | 43 | 73 | 29 |
| P | %wins | 75 | 100 | 100 | 75 | 100 | 75 | 88 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/23/18 19:13 | 10/22/18 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehra Anand | CA | D | P | 4,000 | 10.75 | 0 | 372 | 24 | 1,912 | I | |||||||||||||||
10/13/15 13:26 | 10/13/15 | ACRS | Aclaris Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mehra Anand | PA | DT | P.d | 4,500 | 11.00 | 4 | 409 | 22 | 2,289 | I | 23 | -8 | 13 | 27 | 50 | 47 | 80 | ||||||||
2/6/15 20:06 | 2/4/15 | ONCE | Spark Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mehra Anand | CA | D | P.d | 5,175 | 23.00 | 16 | 225 | 12 | 2,119 | I | -8 | 2 | 3 | 36 | 32 | 31 | -46 | ||||||||
8/7/14 12:43 | 8/5/14 | MRNS | Marinus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Mehra Anand | CA | DT | P.d | 6,005 | 8.00 | 1 | 751 | 28 | I | 1 | 0 | 0 | 4 | -15 | 49 | 129 | |||||||||
10/30/13 16:00 | 10/25/13 | AERI | Aerie Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mehra Anand | CA | DT | P.d | 2,850 | 10.00 | 10 | 285 | 10 | 3,091 | I | 1 | 11 | 12 | 71 | 46 | 128 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |